Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
17,038
Total Claims
$2.2M
Drug Cost
576
Beneficiaries
$3,850
Cost/Patient
Risk Score Breakdown 3/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-74%
Opioid rate vs peers
0.7% vs 2.6% avg
+261%
Cost per patient vs peers
$3,850 vs $1,068 avg
+110%
Brand preference vs peers
18.9% vs 9.0% avg
Opioid Prescribing
0.7%
Opioid Rate
113
Opioid Claims
$327
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 3,043 claims · $2.0M
Generic: 13,079 claims · $235K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 140 | $212K |
| Linagliptin | 158 | $207K |
| Sitagliptin Phosphate | 165 | $202K |
| Budesonide/Formoterol Fumarate | 270 | $135K |
| Fluticasone/Umeclidin/Vilanter | 181 | $132K |
| Apixaban | 126 | $122K |
| Sacubitril/Valsartan | 96 | $94K |
| Semaglutide | 71 | $73K |
| Dapagliflozin Propanediol | 54 | $60K |
| Liraglutide | 30 | $56K |
| Budesonide/Glycopyr/Formoterol | 69 | $56K |
| Semaglutide | 26 | $55K |
| Insulin Glargine,hum.Rec.Anlog | 130 | $47K |
| Insulin Aspart | 105 | $43K |
| Linaclotide | 47 | $42K |
Prescribing Profile
Patient Profile
72
Avg Age
56%
Female
1.30
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data